Compare NeoGenomics Inc. Common Stock (NEO) vs UDR Inc. Common Stock (UDR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NeoGenomics Inc. Common Stock vs UDR Inc. Common Stock — how do they compare? NeoGenomics Inc. Common Stock trades at $16.83 (market cap $2.14B), while UDR Inc. Common Stock trades at $33.9 (market cap $10.93B). The key difference: UDR Inc. Common Stock is far larger — about 5.1× NeoGenomics Inc. Common Stock's market cap, and UDR Inc. Common Stock pays a 5.12% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and UDR Inc. Common Stock for 0 Days on average.
| NEO | UDR | |
|---|---|---|
Market Cap | $2.14B | $10.93B |
Volume | 2,228,400 | 2,607,837 |
Sector | Health | Real Estate |
52-Week High | $19.91 | $41.24 |
52-Week Low | $7.19 | $33.27 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.44B | $16.96B |
Dividend Yield | — | 5.12% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →About UDR Inc. Common Stock
UDR, Inc. is a self-administered real estate investment trust that owns, operates, develops, and redevelops multifamily apartment communities across targeted US markets. The company generates income primarily through leasing apartment homes, with a portfolio concentrated in coastal and Sunbelt metropolitan areas.
Read more on UDR →
